Microbial Oligosaccharides with Biomedical Applications

Mar Drugs. 2021 Jun 21;19(6):350. doi: 10.3390/md19060350.

Abstract

Microbial oligosaccharides have been regarded as one of the most appealing natural products attributable to their potent and selective bioactivities, such as antimicrobial activity, inhibition of α-glucosidases and lipase, interference of cellular recognition and signal transduction, and disruption of cell wall biosynthesis. Accordingly, a handful of bioactive oligosaccharides have been developed for the treatment of bacterial infections and type II diabetes mellitus. Given that naturally occurring oligosaccharides have increasingly gained recognition in recent years, a comprehensive review is needed. The current review highlights the chemical structures, biological activities and divergent biosynthetic origins of three subgroups of oligomers including the acarviosine-containing oligosaccharides, saccharomicins, and orthosomycins.

Keywords: aminooligosaccharide; biomedical applications; biosynthesis; chemical structure; microbial oligosaccharide; orthosomycin; saccharomicin.

Publication types

  • Review

MeSH terms

  • Anti-Bacterial Agents* / chemistry
  • Anti-Bacterial Agents* / isolation & purification
  • Anti-Bacterial Agents* / pharmacology
  • Anti-Bacterial Agents* / therapeutic use
  • Bacteria / drug effects
  • Bacterial Infections / drug therapy
  • Biological Products* / chemistry
  • Biological Products* / isolation & purification
  • Biological Products* / pharmacology
  • Biological Products* / therapeutic use
  • Carbohydrate Metabolism / drug effects
  • Diabetes Mellitus, Type 2 / drug therapy
  • Humans
  • Hypoglycemic Agents* / chemistry
  • Hypoglycemic Agents* / isolation & purification
  • Hypoglycemic Agents* / pharmacology
  • Hypoglycemic Agents* / therapeutic use
  • Oligosaccharides* / chemistry
  • Oligosaccharides* / isolation & purification
  • Oligosaccharides* / pharmacology
  • Oligosaccharides* / therapeutic use

Substances

  • Anti-Bacterial Agents
  • Biological Products
  • Hypoglycemic Agents
  • Oligosaccharides